Clinical Trials Browser

Completed × bivatuzumab mertansine × Breast × Clear all

NCT02254005 2023-10-24

Single Dose Escalation Study of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Metastatic Breast Cancer

Phase 1 Completed

Breast Neoplasms